View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - OPTIMAL - Arm LF-C optimised, R-CHOP 14 - Rituximab 375 / Cyclophosphamide 750 / Doxorubicin 50 / Vincristine 2 / Prednisolone 100, diffuse large B-non-Hodgkin Lymphoma, cycle 2-5
Protocol-ID: 1127 V1.0 (Mini), STUDY OPTIMAL - ARM LF-C optimised, R-CHOP 14, DLBCL, C2-5Study protocol, available to authorized participants only.
Indication(s)
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.06.2018